C12N15/111 - page 13 - CPC Classification Index

#3601

20110281769

2011-11-17

SiRNA targeting beta secretase (BACE)

#3602

20110281756

2011-11-17

Compositions and methods for micro-RNA expression profiling of colorectal cancer

#3603

20110281271

2011-11-17

Oligoribonucleotide or peptide nucleic acid capable of inhibiting activity of hepatitis C virus

#3604

20110275785

2011-11-10

HIGHLY BRANCHED HK PEPTIDES AS EFFECTIVE CARRIERS OF siRNA

#3605

20110275702

2011-11-10

DNA nanostructures that promote cell-cell interaction and use thereof

#3606

20110275533

2011-11-10

Micro-RNAs as Markers for Tumor Progression

#3607

20110274930

2011-11-10

Method for polymerizing a small oligonucleotide, and use of a high-molecular oligonucleotide prepared by the polymerization method

#3608

20110274758

2011-11-10

Microsphere-based composition for preventing and/or reversing new-onset autoimmune diabetes

#3609

20110274706

2011-11-10

NUCLEIC ACID DELIVERY VEHICLE AND USES THEREOF

#3610

20110269951

2011-11-03

siRNA targeting cyclin-dependent kinase inhibitor 1B (p27, Kip1) (CDKN1B)

#3611

20110269814

2011-11-03

2'-F MODIFIED RNA INTERFERENCE AGENTS

#3612

20110269813

2011-11-03

Gene Silencing by Single-Stranded Polynucleotides

#3613

20110263683

2011-10-27

RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)

#3614

20110263680

2011-10-27

Reduced size self-delivering RNAi compounds

#3615

20110263675

2011-10-27

Methods of modulating mesenchymal stem cell differentiation

#3616

20110263459

2011-10-27

DIRECT SELECTION OF STRUCTURALLY DEFINED APTAMERS

#3617

20110263026

2011-10-27

Construction of protein-responsive shRNA/RNAi control system using RNP motif

#3618

20110262406

2011-10-27

COMPOSITIONS AND METHODS FOR TARGETED INACTIVATION OF HIV CELL SURFACE RECEPTORS

#3619

20110257384

2011-10-20

Methods and compositions for the specific inhibition of gene expression by double-stranded RNA

#3620

20110257375

2011-10-20

INCREASING EFFICIENCY OF NUCLEIC ACID DELIVERY IN VIVO USING TARGETING CONJUGATES

#3621

20110251261

2011-10-13

Compositions and methods for inhibition of nucleic acids function

#3622

20110251258

2011-10-13

RNAI CONSTRUCTS AND USES THEREOF

#3623

20110251257

2011-10-13

METHODS AND COMPOSITIONS FOR TREATING NEUROLOGICAL DISEASE

#3624

20110250685

2011-10-13

COMPOSITIONS AND METHODS FOR ENHANCING CELLULAR TRANSPORT OF BIOMOLECULES

#3625

20110250675

2011-10-13

Virus-Like Particle Mediated Cellular Delivery

#3626

20110250591

2011-10-13

Method for selecting SIRNAs from a plurality of SIRNAs for gene silencing

#3627

20110245481

2011-10-06

Method for inhibiting function of micro-RNA

#3628

20110245329

2011-10-06

DOUBLE-STRANDED RNA STRUCTURES AND CONSTRUCTS, AND METHODS FOR GENERATING AND USING THE SAME

#3629

20110245322

2011-10-06

Methods for identifying and compounds useful for increasing the functional activity and cell surface expression of CF-associated mutant cystic fibrosis transmembrane conductance regulator

#3630

20110245320

2011-10-06

Nuclease resistant double-stranded ribonucleic acid

#3631

20110245318

2011-10-06

RNA sequence-specific mediators of RNA interference

#3632

20110244568

2011-10-06

RNA sequence-specific mediators of RNA interference

#3633

20110244561

2011-10-06

SiRNA-mediated gene silencing

#3634

20110244446

2011-10-06

RNA sequence-specific mediators of RNA interference

#3635

20110243880

2011-10-06

Modified polymers for delivery of polynucleotides, method of manufacture, and methods of use thereof

#3636

20110237653

2011-09-29

RNA VECTOR THERAPY METHOD

#3637

20110237648

2011-09-29

RNA interference in skin indications

#3638

20110237643

2011-09-29

Identification of a novel repressor on IFN-lambda promoter and siRNA against ZEB1 and BLIMP-1 to increase IFN-lambda gene activity

#3639

20110237522

2011-09-29

Neutral nanotransporters

#3640

20110237521

2011-09-29

SPLICE SWITCHING OLIGOMERS FOR TNF SUPERFAMILY RECEPTORS AND THEIR USE IN TREATMENT OF DISEASE

#3641

20110237435

2011-09-29

Lipophilic nucleic acid delivery vehicle and methods of use thereof

#3642

20110230548

2011-09-22

MULTICISTRONIC VECTORS AND METHODS FOR THEIR DESIGN

#3643

20110230546

2011-09-22

dsRNA COMPOSITIONS AND METHODS FOR TREATING HPV INFECTION

#3644

20110230543

2011-09-22

Oligoribonucleotide inhibitors of Nrf2 and methods of use thereof for treatment of cancer

#3645

20110230425

2011-09-22

Compositions for protection and cellular delivery of interfering RNA

#3646

20110230410

2011-09-22

Low density lipoprotein receptor-mediated siRNA delivery

#3647

20110229984

2011-09-22

Materials and methods directed to asparagine synthetase and asparaginase therapies

#3648

20110229966

2011-09-22

Nanoparticle-based gene delivery systems

#3649

20110229880

2011-09-22

GENE SILENCING

#3650

20110229558

2011-09-22

AGENT FOR TREATING MYELOFIBROSIS

#3651

20110229484

2011-09-22

Host cell kinases as targets for antiviral therapies against HCV infection

#3652

20110224418

2011-09-15

MODIFIED sIRNA MOLECULES AND USES THEREOF

#3653

20110224277

2011-09-15

Oligomeric compounds and compositions for use in modulation of small non-coding RNAS

#3654

20110224149

2011-09-15

Polynucleotides for use in treating and diagnosing cancers

#3655

20110223665

2011-09-15

ENHANCEMENT OF siRNA SILENCING ACTIVITY USING UNIVERSAL BASES OR MISMATCHES IN THE SENSE STRAND

#3656

20110223656

2011-09-15

MicroRNAs and Uses Thereof

#3657

20110218334

2011-09-08

PHOSPHOROTHIOATE OLIGONUCLEOTIDES AND NON-NUCLEOSIDIC PHOSPHOROTHIOATES AS DELIVERY AGENTS FOR iRNA AGENTS

#3658

20110218234

2011-09-08

Gene vector for inducing transgene-specific immune tolerance

#3659

20110213010

2011-09-01

Methods and compositions for the treatment of Huntington'S disease

#3660

20110213007

2011-09-01

MicroRNAs and uses thereof

#3661

20110207799

2011-08-25

Compositions for targeted delivery of siRNA

#3662

20110207797

2011-08-25

ENHANCED ANTISENSE OLIGONUCLEOTIDES

#3663

20110207625

2011-08-25

PIRNA AND USES RELATED THERETO

#3664

20110207224

2011-08-25

In vivo production of small interfering RNAs that mediate gene silencing

#3665

20110207217

2011-08-25

Modulation of gene expression by oligomers targeted to chromosomal DNA

#3666

20110201798

2011-08-18

Therapeutic compositions

#3667

20110197292

2011-08-11

Delivery method

#3668

20110196142

2011-08-11

DNA molecule for expressing Hairpin RNA, the constructing method and the use thereof

#3669

20110196018

2011-08-11

Nuclease resistant external guide sequences for treating inflammatory and viral related respiratory diseases

#3670

20110195127

2011-08-11

Compositions and methods for silencing apolipoprotein B

#3671

20110195078

2011-08-11

TAT-BASED IMMUNOMODULATORY COMPOSITIONS AND METHODS FOR THEIR DISCOVERY AND USE

#3672

20110189766

2011-08-04

Micrornas and uses thereof

#3673

20110189689

2011-08-04

RIBOSWITCHES

#3674

20110189300

2011-08-04

siRNA SILENCING OF APOLIPOPROTEIN B

#3675

20110189180

2011-08-04

Antigenic compositions and use of same in the targeted delivery of nucleic acids

#3676

20110184045

2011-07-28

SILENCNG AND RIG-I ACTIVATION BY DUAL FUNCTION OLIGONUCLEOTIDES

#3677

20110182880

2011-07-28

Combination Therapies Against Cancer

#3678

20110179501

2011-07-21

Methods for reverting methylation by targeting methyltransferases

#3679

20110178154

2011-07-21

GENE EXPRESSION PROFILE THAT PREDICTS OVARIAN CANCER SUBJECT RESPONSE TO CHEMOTHERAPY

#3680

20110177965

2011-07-21

Compositions and methods for prognosis of gastric cancer

#3681

20110177599

2011-07-21

DELIVERY OF NUCLEIC ACIDS ACROSS MEMBRANES

#3682

20110177160

2011-07-21

Amino acid lipids and uses thereof

#3683

20110177054

2011-07-21

USE OF ENDO-LYSOSOMAL SYSTEM AND SECRETED VESICLES (EXOSOME-LIKE) IN TREATMENTS AND DIAGNOSTICS BASED ON SMALL RNA AND EXPERIMENTAL STUDY OF SMALL RNA

#3684

20110172418

2011-07-14

ANTISENSE RESTENOSIS COMPOSITION AND METHOD

#3685

20110172405

2011-07-14

METHOD FOR SMALL RNA ISOLATION

#3686

20110172292

2011-07-14

ANTIDOTE OLIGOMERS

#3687

20110172291

2011-07-14

RNA interference for the treatment of gain-of-function disorders

#3688

20110172289

2011-07-14

Minor groove binder (MGB)-oligonucleotide miRNA antagonists

#3689

20110172120

2011-07-14

Compositions and Systems for the Regulation of Genes

#3690

20110172107

2011-07-14

ASSAY FOR IDENTIFYING AGENTS THAT MODULATE EPIGENETIC SILENCING, AND AGENTS IDENTIFIED THEREBY

#3691

20110171730

2011-07-14

Conjugates For Use In Hepatocyte Free Uptake Assays

#3692

20110171287

2011-07-14

Use of Oligonucleotides with Modified Bases as Antiviral Agents

#3693

20110171257

2011-07-14

HERPES SIMPLEX VIRUS AMPLICON VECTORS DERIVED FROM PRIMARY ISOLATES

#3694

20110171184

2011-07-14

Method for Introducing a Pna Molecule Conjugated to a Positively Charged Peptide into the Cytosol and/or the Nucleus by Photochemical Internalisation (Pci)

#3695

20110166213

2011-07-07

Method for obtaining oligonucleotide aptamers and uses thereof

#3696

20110166198

2011-07-07

RNA COMPOSITIONS FOR MODULATING IMMUNE RESPONSE

#3697

20110165664

2011-07-07

TRANSFECTION DEVICE UTILIZING SERICIN

#3698

20110160707

2011-06-30

Compositions, devices and methods for treatment of Huntington's disease through intracranial delivery of sirna

#3699

20110160287

2011-06-30

Potentiator of activity of anti-cancer agent and use thereof, and biomarker for prediction of prognosis in cancer patient and use thereof

#3700

20110160286

2011-06-30

Allele-specific RNA interference

#3701

20110160284

2011-06-30

Supercoiled minivectors™ for gene therapy applications

#3702

20110159586

2011-06-30

COMPOSITIONS AND METHODS FOR MODULATING GENE EXPRESSION USING ASYMMETRICALLY-ACTIVE PRECURSOR POLYNUCLEOTIDES

#3703

20110159098

2011-06-30

STABILIZATION AND DELIVERY OF NUCLEIC ACID COMPLEXES

#3704

20110158937

2011-06-30

SYNERGISTIC STIMULATION OF THE IMMUNE SYSTEM USING IMMUNOSTIMULATORY OLIGONUCLEOTIDES AND/OR IMMUNOMER COMPOUNDS IN CONJUNCTION WITH CYTOKINES AND/OR CHEMOTHERAPEUTIC AGENTS OR RADIATION THERAPY

#3705

20110152353

2011-06-23

Double-stranded polynucleotide

#3706

20110152352

2011-06-23

SMAD PROTEINS CONTROL DROSHA-MEDIATED MIRNA MATURATION

#3707

20110152347

2011-06-23

Methods and compositions for controlling efficacy of RNA silencing

#3708

20110152346

2011-06-23

Use of Oligonucleotides with Modified Bases in Hybridization of Nucleic Acids

#3709

20110151558

2011-06-23

METHODS AND COMPOSITIONS FOR REDUCING TARGET GENE EXPRESSION USING COCKTAILS OF siRNAS OR CONSTRUCTS EXPRESSING siRNAS

#3710

20110151430

2011-06-23

VIRUS-SPECIFIC miRNA SIGNATURES FOR DIAGNOSIS AND THERAPEUTIC TREATMENT OF VIRAL INFECTION

#3711

20110151013

2011-06-23

Amphiphilic block copolymers for nucleic acid delivery

#3712

20110150863

2011-06-23

Modulation of immunostimulatory properties of oligonucleotide-based compounds by utilizing modified immunostimulatory dinucleotides

#3713

20110143434

2011-06-16

Diblock copolymers and polynucleotide complexes thereof for delivery into cells

#3714

20110143400

2011-06-16

SIRNA AND METHODS OF MANUFACTURE

#3715

20110143359

2011-06-16

Method for Identifying Drug-Sensitizing Antisense DNA Fragments and Use Thereof

#3716

20110143338

2011-06-16

Nucleic acid enzymes and complexes and methods for their use

#3717

20110142951

2011-06-16

MICELLES FOR INTRACELLULAR DELIVERY OF THERAPEUTIC AGENTS

#3718

20110131668

2011-06-02

IMPROVED GENE SILENCING METHODS

#3719

20110130557

2011-06-02

INTERCALATING TRIPLEXES AND DUPLEXES USING ARYL NAPHTHOIMIDAZOL AND PROCESS FOR THE PREPARATION THEREOF

#3720

20110130440

2011-06-02

NON-NATURAL RIBONUCLEOTIDES, AND METHODS OF USE THEREOF

#3721

20110129461

2011-06-02

MAT II β subunit RNAi and therapeutic methods using same

#3722

20110126321

2011-05-26

Recombinant DNA for gene suppression

#3723

20110125075

2011-05-26

METHOD FOR CONTROL OF ELECTROPORATION APPARATUS

#3724

20110124713

2011-05-26

SAM-II RIBOSWITCH AND USES THEREOF

#3725

20110124707

2011-05-26

Methods and compositions for reducing viral genome amounts in a target cell

#3726

20110124591

2011-05-26

Compounds and methods for modulating protein expression

#3727

20110124108

2011-05-26

EPIGENETIC ENGINEERING

#3728

20110124015

2011-05-26

APTAMER-BASED METHODS FOR IDENTIFYING CELLULAR BIOMARKERS

#3729

20110123988

2011-05-26

ANTISENSE COMPOUNDS AND METHODS FOR DIAGNOSTIC IMAGING

#3730

20110123636

2011-05-26

Micellic assemblies

#3731

20110123520

2011-05-26

Site-specific delivery of nucleic acids by combining targeting ligands with endosomolytic components

#3732

20110118456

2011-05-19

Interfering RNA molecules

#3733

20110118340

2011-05-19

DELIVERY OF RNAI CONSTRUCTS TO OLIGODENDROCYTES

#3734

20110118332

2011-05-19

Viral microRNA

#3735

20110118331

2011-05-19

Cationic siRNAs, synthesis and use for RNA interference

#3736

20110118140

2011-05-19

METHODS FOR IDENTIFICATION, AND COMPOUNDS USEFUL FOR THE TREATMENT OF DEGENERATIVE & INFLAMMATORY DISEASES

#3737

20110117608

2011-05-19

DOUBLE-STRANDED NUCLEIC ACID

#3738

20110117111

2011-05-19

MICRORNA-BASED DIAGNOSTIC TESTING AND THERAPIES FOR INFLAMMATORY BOWEL DISEASE AND RELATED DISEASES

#3739

20110112283

2011-05-12

RNA interference mediating small RNA molecules

#3740

20110112173

2011-05-12

Methods and compositions involving microRNA

#3741

20110112170

2011-05-12

Oligomeric compounds comprising bicyclic nucleosides and having reduced toxicity

#3742

20110112169

2011-05-12

RNAi-BASED THERAPEUTICS FOR ALLERGIC RHINITIS AND ASTHMA

#3743

20110112168

2011-05-12

Double-stranded RNA directed to CASP2 and methods of use thereof

#3744

20110111983

2011-05-12

siRNA targeting spleen tyrosine kinase

#3745

20110111501

2011-05-12

Complex of polysaccharide and double-stranded RNA

#3746

20110111496

2011-05-12

BACTERIA-MEDIATED GENE MODULATION VIA microRNA MACHINERY

#3747

20110111493

2011-05-12

Compositions and methods for inhibiting expression of a target gene

#3748

20110111491

2011-05-12

RNA interference suppresion of neurodegenerative diseases and methods of use thereof

#3749

20110111481

2011-05-12

ENABLING THE USE OF LONG dsRNA FOR GENE TARGETING IN MAMMALIAN AND OTHER SELECTED ANIMAL CELLS

#3750

20110111056

2011-05-12

PEPTIDE DICER SUBSTRATE AGENTS AND METHODS FOR THEIR SPECIFIC INHIBITION OF GENE EXPRESSION

#3751

20110111041

2011-05-12

Bacterially derived intact minicells that encompass plasmid free functional nucleic acid for in vivo delivery to mammalian cells

#3752

20110110960

2011-05-12

Mannose-6-phosphate receptor mediated gene transfer into muscle cells

#3753

20110110883

2011-05-12

Methods of altering an immune response induced by CpG oligodeoxynucleotides

#3754

20110105740

2011-05-05

SOLUBLE TNF RECEPTORS AND THEIR USE IN TREATMENT OF DISEASE

#3755

20110105593

2011-05-05

MicroRNA-Formatted Multitarget Interfering RNA Vector Constructs and Methods of Using The Same

#3756

20110105583

2011-05-05

Methods of using MIR34 as a biomarker for TP53 functional status

#3757

20110105413

2011-05-05

POLYMERIC SYSTEMS CONTAINING INTRACELLULAR RELEASABLE DISULFIDE LINKER FOR THE DELIVERY OF OLIGONUCLEOTIDES

#3758

20110105363

2011-05-05

siRNA targeting TNFa

#3759

20110104255

2011-05-05

THERAPEUTIC AGENT FOR FIBROID LUNG

#3760

20110098200

2011-04-28

Methods using dsdna to mediate rna interference (rnai)

#3761

20110097721

2011-04-28

In vivo gene sensors

#3762

20110097720

2011-04-28

SCREENING METHOD FOR SELECTED AMINO LIPID-CONTAINING COMPOSITIONS

#3763

20110097707

2011-04-28

RNAi Agents Comprising Universal Nucleobases

#3764

20110097390

2011-04-28

Ultra-small RNAs as toll-like receptor-3 antagonists

#3765

20110097328

2011-04-28

Methods and compositions for increasing the activity of inhibitory RNA

#3766

20110091893

2011-04-21

Biosensors for detecting macromolecules and other analytes

#3767

20110091523

2011-04-21

Cochleate compositions directed against expression of proteins

#3768

20110086425

2011-04-14

DELIVERY OF siRNAs

#3769

20110086044

2011-04-14

Compositions and Methods to Inhibit HPV Infection

#3770

20110081717

2011-04-07

Double-stranded nucleic acid molecule, cancer cell proliferation inhibitor and pharmaceutical agent suitable for prevention or treatment of cancer

#3771

20110081362

2011-04-07

TREATMENT OF CANCER

#3772

20110079528

2011-04-07

Oligonucleotide compositions and methods for treating disease including inflammatory conditions

#3773

20110077286

2011-03-31

Oligonucleotide duplexes comprising DNA-like and RNA-like nucleotides and uses thereof

#3774

20110077284

2011-03-31

DRY POWDER COMPOSITIONS FOR RNA INFLUENZA THERAPEUTICS

#3775

20110077173

2011-03-31

siRNA targeting tie-2

#3776

20110076335

2011-03-31

Lipid formulations for nucleic acid delivery

#3777

20110071208

2011-03-24

LIPID ENCAPSULATED DICER-SUBSTRATE INTERFERING RNA

#3778

20110071049

2011-03-24

METHODS AND COMPOSITIONS FOR TRANSLATIONAL PROFILING AND MOLECULAR PHENOTYPING

#3779

20110070162

2011-03-24

RNA interference mediating small RNA molecules

#3780

20110065908

2011-03-17

METHODS AND COMPOSITIONS FOR THE SPECIFIC INHIBITION OF GENE EXPRESSION BY DOUBLE-STRANDED RNA

#3781

20110065807

2011-03-17

PH sensitive biodegradable polymeric particles for drug delivery

#3782

20110065774

2011-03-17

CHEMICALLY MODIFIED OLIGONUCLEOTIDES AND USES THEREOF

#3783

20110065773

2011-03-17

RNA interference mediating small RNA molecules

#3784

20110065770

2011-03-17

Formulations comprising antisense nucleotides to connexins

#3785

20110065109

2011-03-17

RNA interference mediating small RNA molecules

#3786

20110065087

2011-03-17

NOVEL HIV TARGETS

#3787

20110064792

2011-03-17

Method for opening tight junctions

#3788

20110060123

2011-03-10

CHARGE CONVERSIONAL TERNARY POLYPLEX

#3789

20110060032

2011-03-10

Lipid encapsulating interfering RNA

#3790

20110059187

2011-03-10

PEPTIDE DICER SUBSTRATE AGENTS AND METHODS FOR THEIR SPECIFIC INHIBITION OF GENE EXPRESSION

#3791

20110055965

2011-03-03

CYCLE SINGLE-STRANDED NUCLEIC ACID COMPLEX AND METHOD FOR PRODUCING THE SAME

#3792

20110054160

2011-03-03

Therapeutic compositions

#3793

20110054159

2011-03-03

RNA interference mediating small RNA molecules

#3794

20110054005

2011-03-03

Polynucleotides for causing RNA interference and method for inhibiting gene expression using the same

#3795

20110053802

2011-03-03

CATEGORIZATION OF MICROBIAL COMMUNITIES

#3796

20110052601

2011-03-03

COMPOSITIONS COMPRISING ANTI-ICAM-1 ANTIBODIES

#3797

20110046209

2011-02-24

RNA-induced translational silencing and cellular apoptosis

#3798

20110046206

2011-02-24

DOUBLE STRAND COMPOSITIONS COMPRISING DIFFERENTIALLY MODIFIED STRANDS FOR USE IN GENE MODULATION

#3799

20110046201

2011-02-24

METHODS AND COMPOSITIONS FOR SEAMLESS CLONING OF NUCLEIC ACID MOLECULES

#3800

20110046200

2011-02-24

Use of antisense oligonucleotides to effect translation modulation

#3801

20110045473

2011-02-24

LIVER SCREENING METHOD

#3802

20110045080

2011-02-24

Single-Walled Carbon Nanotube/Bioactive Substance Complexes and Methods Related Thereto

#3803

20110045001

2011-02-24

Transfection results of non-viral gene delivery systems by influencing of the innate immune system

#3804

20110044931

2011-02-24

Multi-conjugate of siRNA and preparing method thereof

#3805

20110039915

2011-02-17

Immunostimulatory siRNA molecules

#3806

20110039914

2011-02-17

Modified RNAi polynucleotides and uses thereof

#3807

20110039734

2011-02-17

siRNA targeting connective tissue growth factor (CTGF)

#3808

20110039334

2011-02-17

Chimeric oligomeric compounds for modulation of splicing

#3809

20110038849

2011-02-17

INHIBITORY POLYNUCLEOTIDE COMPOSITIONS AND METHODS FOR TREATING CANCER

#3810

20110034545

2011-02-10

Double-stranded lipid-modified RNA having high RNA interference effect

#3811

20110034535

2011-02-10

Positive controls for expression modulating experiments

#3812

20110034349

2011-02-10

SiRNA targeting proto-oncogene MET

#3813

20110033860

2011-02-10

Method For Searching Target Base Sequence Of Rna Interference, Method For Designing Base Sequence Of Polynucleotide For Causing Rna Interference, Method For Producing Double-Stranded Polynucleotide, Method For Inhibiting Gene Expression, Base Sequence Processing Apparatus, Program For Running Base Sequence Processing Method On Computer, Recording Medium, And Base Sequence Processing System

#3814

20110033551

2011-02-10

Nucleic acid microspheres, production and delivery thereof

#3815

20110033547

2011-02-10

DEHYDRATED CHITOSAN NANOPARTICLES

#3816

20110028534

2011-02-03

RNAi INHIBITION OF CTGF FOR TREATMENT OF OCULAR DISORDERS

#3817

20110027883

2011-02-03

RNA interference mediating small RNA molecules

#3818

20110027882

2011-02-03

Methods and Compositions for Treating Neurological Disease

#3819

20110027851

2011-02-03

Compositions, methods and uses for biosynthetic plasmid integrated capture elements

#3820

20110027239

2011-02-03

ADIPOSE-DERIVED STROMAL CELLS (ASC) AS DELIVERY TOOL FOR TREATMENT OF CANCER

#3821

20110021605

2011-01-27

MEANS AND METHODS FOR THE SPECIFIC INHIBITION OF GENES IN CELLS AND TISSUE OF THE CNS AND/OR EYE

#3822

20110021382

2011-01-27

siRNA targeting amyloid beta (A4) precursor protein (APP)

#3823

20110020816

2011-01-27

Precursor miRNA loop-modulated target regulation

#3824

20110020234

2011-01-27

RNA interference mediating small RNA molecules

#3825

20110014293

2011-01-20

Cleavage kit, and gene therapy by using the same and nucleic acid cleavage detection apparatus

#3826

20110014123

2011-01-20

RNA interference mediating small RNA molecules

#3827

20110009466

2011-01-13

METHODS OF INCREASING GENE EXPRESSION THROUGH RNA PROTECTION

#3828

20110009281

2011-01-13

Methods for creating and identifying functional RNA interference elements

#3829

20110008885

2011-01-13

LINEAR DOUBLE-STRANDED RNA MOLECULE INTERFERING WITH DIFFERENT TARGET GENES

#3830

20110008451

2011-01-13

Compositions and methods for controlled delivery of inhibitory ribonucleic acids

#3831

20110008395

2011-01-13

MIXED MICELLES INCLUDING AMPHIPATHIC CONJUGATES OF RNA AGENTS, AND USES THEREOF

#3832

20110003883

2011-01-06

ALLOSTERIC TRANS-SPLICING GROUP I RIBOZYME WHOSE ACTIVITY OF TARGET-SPECIFIC RNA REPLACEMENT IS CONTROLLED BY THEOPHYLLINE

#3833

20110003881

2011-01-06

Single stranded extended dicer substrate agents and methods for the specific inhibition of gene expression

#3834

20110003879

2011-01-06

Antisense oligonucleotides targeted to the coding region of thymidylate synthase and uses thereof

#3835

20110003714

2011-01-06

siRNA targeting beta secretase (BACE)

#3836

20110003713

2011-01-06

siRNA targeting apolipoprotein B (APOB)

#3837

20110003378

2011-01-06

Multiple promoter expression cassettes for simultaneous delivery of RNAi agents

#3838

20110003307

2011-01-06

Methods for producing interfering RNA molecules in mammalian cells and therapeutic uses for such molecules

#3839

20110002892

2011-01-06

Modular aptamer-regulated ribozymes

#3840

20100331392

2010-12-30

Antidotes to antisense compounds

#3841

20100331389

2010-12-30

Compositions and methods for the specific inhibition of gene expression by dsRNA containing modified nucleotides

#3842

20100331234

2010-12-30

Aminoalcohol lipidoids and uses thereof

#3843

20100331214

2010-12-30

siRNA Targeting Survivin

#3844

20100330155

2010-12-30

METHODS AND COMPOSITIONS FOR IMPROVED THERAPEUTIC EFFECTS WITH siRNA

#3845

20100324122

2010-12-23

Modulation of SGLT2 expression

#3846

20100324121

2010-12-23

METHODS AND COMPOSITIONS FOR THE SPECIFIC INHIBITION OF GENE EXPRESSION BY DOUBLE-STRANDED RNA

#3847

20100324113

2010-12-23

Delivery Method

#3848

20100323922

2010-12-23

siRNA targeting TATA box binding protein (TBP)-associated factor (TAF1)

#3849

20100323356

2010-12-23

Small RNA-dependent translational regulatory system in cell or artificial cell model

#3850

20100323018

2010-12-23

Branched DNA/RNA monomers and uses thereof

#3851

20100323001

2010-12-23

In vivo delivery of double stranded RNA to a target cell

#3852

20100317714

2010-12-16

COMPLEX MOLECULE INTERFERING THE EXPRESSION OF TARGET GENES AND ITS PREPARING METHODS

#3853

20100317105

2010-12-16

Methods and compositions for controlling efficacy of RNA silencing

#3854

20100317049

2010-12-16

Stable cell lines and methods for evaluating gastrointestinal absorption of chemicals

#3855

20100316707

2010-12-16

Methods and compositions for enhancing delivery of double-stranded RNA or a double-stranded hybrid nucleic acid to regulate gene expression in mammalian cells

#3856

20100316703

2010-12-16

RNA interference mediating small RNA molecules

#3857

20100311958

2010-12-09

CARRIER, METHOD AND REAGENT FOR OBTAINING SMALL RNA

#3858

20100311808

2010-12-09

Methods, compositions and drug delivery systems for intraocular delivery of siRNA molecules

#3859

20100311082

2010-12-09

Stable cell lines and methods for evaluating gastrointestinal absorption of chemicals

#3860

20100311048

2010-12-09

Nucleic acids encoding SOX10 promoter and methods to isolate SOX10 expressing cells

#3861

20100310473

2010-12-09

Targeting Brain Cells Via Ophthalmic Delivery

#3862

20100306869

2010-12-02

MODULATING PRODUCTION TRAITS IN AVIANS

#3863

20100305197

2010-12-02

Conditionally Active Ribozymes And Uses Thereof

#3864

20100305191

2010-12-02

RNA INTERFERENCE MEDIATED INHIBITION OF ADENOSINE A1 RECEPTOR (ADORA1) GENE EXPRESSION USING SHORT INTERFERING RNA

#3865

20100305186

2010-12-02

METHODS FOR MEDIATING GENE SUPPRESSION

#3866

20100303859

2010-12-02

Vectors and method for genetic immunization

#3867

20100303803

2010-12-02

CATENATE FOR IMMUNOSTIMULATION

#3868

20100303802

2010-12-02

Antibodies directed to mGluR7

#3869

20100303776

2010-12-02

Methods and compositions for regulated expression of multiple nucleic acids

#3870

20100299771

2010-11-25

MEANS AND METHODS FOR shRNA MEDIATED CONDITIONAL KNOCKDOWN OF GENES

#3871

20100298697

2010-11-25

METHOD AND DEVICES FOR IMPROVED EFFICIENCY OF RNA DELIVERY TO CELLS

#3872

20100298410

2010-11-25

MicromiRs

#3873

20100298408

2010-11-25

Oligonucleotide Compositions with Enhanced Efficiency

#3874

20100298152

2010-11-25

USE OF APTAMERS IN PROTEOMICS

#3875

20100297756

2010-11-25

MEANS FOR DELIVERY OF NUCLEIC ACIDS ACTIVE FOR GENE SILENCING USING SYNTHETIC POLYMERS

#3876

20100297654

2010-11-25

Three-component biosensors for detecting macromolecules and other analytes

#3877

20100297023

2010-11-25

Lipid

#3878

20100292456

2010-11-18

RNA interference mediating small RNA molecules

#3879

20100292455

2010-11-18

Modified iRNA agents

#3880

20100292310

2010-11-18

Micro-RNA scaffolds and non-naturally occurring micro-RNAs

#3881

20100292304

2010-11-18

Compounds and methods for improving cellular uptake of oligomeric compounds

#3882

20100292301

2010-11-18

NOVEL SIRNA STRUCTURES

#3883

20100292299

2010-11-18

Nucleotide Motifs Providing Localization Elements and Methods of Use

#3884

20100291681

2010-11-18

Methods and compositions for selecting siRNA of improved functionality

#3885

20100291673

2010-11-18

Alternative export pathways for vector expressed RNA interference

#3886

20100291561

2010-11-18

Methods for detecting a target nucleotide sequence in a sample utilising a nuclease-aptamer complex

#3887

20100291194

2010-11-18

Compositions and methods for inhibiting expression of a mutant gene

#3888

20100286378

2010-11-11

Composition of Asymmetric RNA Duplex As MicroRNA Mimetic or Inhibitor

#3889

20100286237

2010-11-11

Pro-angiogenic genes in ovarian tumor endothelial cell isolates

#3890

20100285484

2010-11-11

Apoptosis inducing positive control for expression modulation experiments

#3891

20100280102

2010-11-04

DOUBLE-STRANDED RIBONUCLEIC ACID WITH INCREASED EFFECTIVENESS IN AN ORGANISM

#3892

20100280099

2010-11-04

Combination treatment for the treatment of hepatitis C virus infection

#3893

20100280098

2010-11-04

RECEPTOR TARGETED OLIGONUCLEOTIDES

#3894

20100279896

2010-11-04

siRNA targeting interleukin-1 receptor-associated kinase 4(IRAK4)

#3895

20100279408

2010-11-04

POLYMERIC SHORT INTERFERING RNA CONJUGATES

#3896

20100279292

2010-11-04

MicroRNA expression in human peripheral blood microvesicles and uses thereof

#3897

20100273863

2010-10-28

Modulation of gene expression using oligomers that target gene regions downstream of 3′ untranslated regions

#3898

20100273859

2010-10-28

TREATMENT AND PREVENTION OF HIV INFECTION

#3899

20100273856

2010-10-28

Screening of micro-RNA cluster inhibitor pools

#3900

20100272813

2010-10-28

NANOPARTICLE-MEDIATED TREATMENT FOR INFLAMMATORY DISEASES